Clinical Trial Update: Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African Americans [Phase 1]

View source ↗

Summary

Phase 1 study completed examining how genetic variants in MATE1 and OCT3 alter metformin pharmacodynamics in African Americans, including healthy volunteers and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Healthy, Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED